- Home
- CLMB vs MREO Comparison
CLMB vs MREO Comparison
Compare CLMB & MREO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLMB
- MREO
- Stock Information
- Founded
- CLMB 1982
- MREO 2015
- Country
- CLMB United States
- MREO United Kingdom
- Employees
- CLMB N/A
- MREO N/A
- Industry
- CLMB Retail: Computer Software & Peripheral Equipment
- MREO Biotechnology: Pharmaceutical Preparations
- Sector
- CLMB Technology
- MREO Health Care
- Exchange
- CLMB Nasdaq
- MREO Nasdaq
- Market Cap
- CLMB 542.4M
- MREO 482.5M
- IPO Year
- CLMB N/A
- MREO N/A
- Fundamental
- Price
- CLMB $111.21
- MREO $2.50
- Analyst Decision
- CLMB Buy
- MREO Strong Buy
- Analyst Count
- CLMB 1
- MREO 6
- Target Price
- CLMB $136.00
- MREO $7.83
- AVG Volume (30 Days)
- CLMB 42.7K
- MREO 1.5M
- Earning Date
- CLMB 03-05-2025
- MREO 03-26-2025
- Dividend Yield
- CLMB 0.61%
- MREO N/A
- EPS Growth
- CLMB 49.26
- MREO N/A
- EPS
- CLMB 4.06
- MREO N/A
- Revenue
- CLMB $465,607,000.00
- MREO $1,000,000.00
- Revenue This Year
- CLMB $7.01
- MREO N/A
- Revenue Next Year
- CLMB N/A
- MREO N/A
- P/E Ratio
- CLMB $27.41
- MREO N/A
- Revenue Growth
- CLMB 32.27
- MREO N/A
- 52 Week Low
- CLMB $49.70
- MREO $2.25
- 52 Week High
- CLMB $145.00
- MREO $5.02
- Technical
- Relative Strength Index (RSI)
- CLMB 36.56
- MREO 38.26
- Support Level
- CLMB $118.23
- MREO $2.39
- Resistance Level
- CLMB $125.00
- MREO $2.59
- Average True Range (ATR)
- CLMB 7.35
- MREO 0.17
- MACD
- CLMB -0.72
- MREO 0.02
- Stochastic Oscillator
- CLMB 0.59
- MREO 39.87
About CLMB Climb Global Solutions Inc.
Climb Global Solutions Inc is a cloud-based, value-added IT distribution and solutions company specializing in emerging technologies. It operates across the USA, Canada, and Europe through multiple business units, including Climb Channel Solutions, Sigma, Grey Matter, Interwork, and TechXtend. The Company is organized into two reportable operating segments. The Distribution segment distributes technical software to corporate resellers, value-added resellers (VARs), consultants, and systems integrators under the name Climb Channel Solutions. The Solutions segment is a cloud solutions provider and value-added reseller of software, hardware, and services to customers under the name Grey Matter.
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of innovative therapeutics for rare diseases. The Company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).